Click2Clinic Malaysia - IM

Click2Clinic Malaysia Sdn Bhd
Click2Clinic
Bridges Healthcare Providers and Patient communities Globally
Investment
Memorandum
2017
CONNECTED CLINICAL BUY HEALTH AT YOUR CALL ANY DOCTOR CURE AT YOUR
COMMUNITIES PRICE ANYWHERE ANY TME COCOON
PRIVATE AND CONFIDENTIAL

Dear Investor,
The boards of directors of Click2Clinc Malaysia Sdn Bhd are excited to offer you the opportunity to
invest in our company. We have a successful track record, world-class investors and there is a huge
global market for healthcare technology startups.
Digital technology is changing the world very quickly. Digital Healthcare, Virtual Video consultations,
Auctioning and Bidding to get Healthcare at Lowest price, Remote clinical monitoring on Telemedicine
platform, technology enabled medical tourism , social community with global connections among
patients and Healthcare providers on mobile apps is the future of clinical practice . Conventional
hospital care in Geriatric medicine is fast shifting to Home Healthcare practice. The established players
are losing out to young upstart Internet companies evolving disruptive mobile technology. Silicon Valley
in America has created several of the worlds most valuable companies like Apple, Google and
Facebook in less than 20 years.
Click2Clinic Inc, the holding company is incorporated as Silicon Valley Startup in Jan 2016 with a vision
to works in joint venture with entrepreneurs in 130 countries globally to build the next generation of
Digital Healthcare businesses.
Our investors form a strong network of mentors, which include the practicing medical consultants in
Cardiology, Neurology, Nephrology, Rheumatology. They are from diverse background from
entrepreneurs who built large Cargo Company, corporate banker in Europe. Our Board includes people
who have served as CEO's of Reliance communications, Aircel, Medical school Deans, bureaucrats who
worked in Healthcare policy making of Asian countries and implemented many Telemedicine projects
in remote, rural terrains in Asia . We share a vision to create worlds largest well connected collaborative
clinical communities, support groups of patients and enable them to discover Healthcare providers at
affordable price anytime, any where across globe by leveraging on state of art mobile technologies
powered by Big data , Analytics .
We believe that makes our company unique in 7 countries in South East Asia namely India, Bangladesh,
Pakistan, Nepal, Sri Lanka, Maldives, Bhutan.
Click2Clinic Healthcare India Pvt Ltd is established in Jan 2016 to take advantage of the fast growing
opportunities in these huge markets.
To support this growth, Click2Clinic Malaysia Sdn Bhd is raising up to $ 1 Million by issuing 66,66,667
shares at $0.15 each. Detailed information on the company and the proposed investment opportunity is
contained in this Information Memorandum. Please study this Information Memorandum and decide if
this is right for you.
We hope that you will decide to become a shareholder and join us in a very exciting journey.
Dr Sujeeth Punnam
Chairman
www.click2clinic.com 1
Investor
Testimonials
DR. RONALD A. KASS, MD
Pulmonologist, California

Angel Investor Click2Clinic Healthcare Inc
Telemedicine, Virtual Consults is the future

of out- patient healthcare . Many digital
startups in North America made first move .
Click2Clinic adds a strong process on the
mobile technology platform to connect
supply chain of Health care providers and
patients on demand. I have invested in
Click2Clinic with a strong conviction on

concept and technology being a
practicing Pulmonologist for 2 decades.
SRINIVAS SATTIRAJU
Founder and CEO Delex Cargo India
I founded a 250 Million dollar values

enterprise Delex Cargo India and head a
1500 employee organization .My investment
in Click2Clinic has gone well beyond the
conventional passive investment, and
instead has introduced me to a dynamic
network of experienced and successful
entrepreneurs, investors, and passionate,
hungry start up entrepreneurs. The

atmosphere and culture at Click2Clinic
isagile , task oriented and results driven .
RAVINDRA MADDURI M.TECH,MBA
Corprate Banker Director Barclays London
The main reason I invested in Click2Clinic is

that I see a mismatch between the risk and
the potential rewards of startups. The returns
can be high and traditionally the risks are also
high. By having previously successful
entrepreneurs investing in and mentoring
enthusiastic Co-founding team, I believe the
risks while still high, can be reduced to the

point that the potential rewards are attractive.
DR RANDEEP BAJWA MD
Nephrologist California

Lot of times, startups build technology apps

passionately that facilitate clinical practice of
Healthcare providers . When it comes to
bringing business to the supply chain of
healthcare providers by bringing their visibility
to demand side of patients , many Healthcare
Tech startups are stuck . I found it completely
different and a disruptive strategy in the
product line of Click2Clinic . They are building
a social networking app that brings
connections between one patient to other
patient with same clinical condition globally
and enables to form patient support groups
and communities on the mobile platform .
Same time Click2Clinic is creating mobile
technology to enable aggregation of
Healthcare Service providers . That way
Click2Clinic is creating a win-win business
model to connect Billions of patients globally
on Social network platform with millions of
Healthcare Service provider supply chain on
mobile app .Strategically , they discovered
this unique business model after pivoting in

agile way to the market demands every time
their Sales tem is feet on street.
Summary of
Investment
Opportunity
KEY TERMS
Issuer Click2Clinic Malaysia Sdn Bhd
Price per Share $0.15
Minimum subscription per Shareholder ($) $18,000
Minimum parcel of Shares per Shareholder (Shares) 1,20,000 Shares
Minimum additional investments ($) $4500
Minimum additional investments (Shares) 30,000 Shares
Maximum total subscription ($) $1,000,000
Maximum total subscription (Shares) 66,66,667 Shares
INDICATIVE TIMETABLE
Date of IM 1 Jan 2017
Closing Date 31 Mar 2017
* This may be extended by the Company in its absolute discretion, without notice.
IMPORTANT INFORMATION
Disclaimer
This IM and all information (whether in writing or otherwise which may subsequently be made available
to you ( Subsequent Information is provided on the terms and conditions set out in this
Important Information section. If the terms and conditions set out in this Important Information section
are not acceptable to you, then this IM and any Subsequent Information must be returned immediately
to the Company. Retention of this IM and any Subsequent Information will be deemed to constitute
acceptance by you of the terms and conditions set out in this Important Information section.
No representations
You warrant that you do not (and agree that you will not rely on this IM or any Subsequent Information
or any other statement, warranty, representation, express or implied, made by the Company or any of
its officers, employees, agents, advisers, consultants or other representatives (Representatives in
connection with making a decision about whether or not to invest in the Company.
Forward looking statements
Any statements of opinion, belief, projections, forecasts or statements relating to expectations in this
IM that constitute statements relating to future acts, events and circumstances are for example only
and do not assure the current or future performance of the Company. The Company offers no
assurance or guarantee or warranty that those acts, events and circumstances will occur or arise in
the manner in which they are portrayed in this document, and investors must be aware that they may
not occur or arise in the way in which they are portrayed. No representation is made or assurance
given that such statements, views, projections or forecasts are reasonable or correct.
No AMEX Listing
The Company is not currently listed on any stock exchange. The Company does not intend to apply
for the listing of shares on the American Stock Exchange, or any otherexchange.
Risk
Investment in the Company is speculative and will involve significant risks, due to the nature of the
business of the Clck2Clinic Malaysia Sdn Bhd . The Company is not a suitable investment for
persons unable to sustain a loss of all or part of the sum invested or who require certain or
predictable income flows. Investors should have the financial ability and willingness to accept the
risks and lack of liquidity that are characteristic of the investments described in this IM. Prospective
investors should carefully review section 10 of this IM (Investment Risk).
Neither the Company, nor its Representatives, guarantee the performance of the Company, the
return of investment capital, the payment of any particular return or the increase in value for the
Company, its assets or your investment. An investment in the Company should be considered
speculative in nature.
Taxation
The acquisition of Shares under this IM may have taxation consequences depending on the
personal circumstances of applicants. Applicants should seek professional advice on their taxation
position with regard to any prospective investment.
Professional advice
Investors should obtain professional investment advice before accepting any offer contained in this IM.
This IM does not contain all information you may require before deciding whether to invest in the
Company. In preparing this IM, the Company has taken no account of the investment objectives, financial
situation and particular needs of any particular person, and prospective investors must not construe the
contents of this IM as tax, legal or financial product advice. Before making any investment decision,
prospective investors should seek and rely on their own professional advice, in particular by obtaining
appropriate tax, legal, financial and investment advice in light of their own circumstances and conduct
their own independent investigation and analysis regarding any information contained in this IM.
Privacy statement
If you complete an application for Shares, you will be providing personal information to the Company.
The Company collects, holds and will use that information to assess your application, service your
needs as a Shareholder and to facilitate distribution of payments and corporate communications and
notification of meetings (via postal service, fax or electronic means to you as a Shareholder. The
information may also be used from time to time and disclosed to persons inspecting the register, such
as regulatory bodies, including the United States of America Taxation Office; authorized securities
brokers; print service providers and mail houses.
Collection, maintenance and disclosure of certain personal information is governed by legislation

including the Privacy Act of 1974 , a United States federal law and the United States corporate law .
You should note that if you do not provide the information required on the application for Shares, the
Company may not be able to accept or process your application.
Confidentiality
You acknowledge and agree that the information contained in this IM is confidential in nature, other
than information which is in the public domain through other means, and that any disclosure or use of
such information by you may cause serious harm or damage to the Company. You agree not to
reproduce or disclose any information contained in this IM (or any part of it to any party, other than to
your professional advisers for the purpose of obtaining advice in connection with the Investment
Opportunity contained in this IM, without approval in writing from the Company (which may be
withheld by the Company in its absolute discretion.
Other Important Information
1. This IM has been issued by, and contains information concerning the Company and the
Investment Opportunity. It is provided on a non-transferable basis for your confidential use only.
2. No part of this IM or any Subsequent Information may be reproduced or used for any other
purpose.
3. Neither the Company, nor any of its Representatives (which also includes but is not limited to
the persons named or described in this IM) warrant or represent, either expressly or by
implication, that this IM or any Subsequent Information is complete or has been subject to any
audit, examination or verification to confirm its accuracy.
4. If you proceed with an investment in the Company, you must rely solely on your own
independent review, investigation and analysis. You agree you will not hold the Company or its
representatives liable in any way whatsoever (whether in contract, negligence, equity or
otherwise) as a result or by reason of the provision of this IM or any Subsequent Information to
you or any other person.
5. This IM is not a Product Disclosure Statement or Prospectus; it has not been lodged with U.S.
Securities and. Exchange Commission; and is not regulated by Section 5(b)(2) of the Securities
Act
Glossary
Certain terms used in this IM are dened in the Glossary in section 12 of this IM.
THIS DOCUMENT IS IMPORTANT AND SHOULD BE READ IN ITS

ENTIRETY BEFORE DECIDING TO INVEST.
Table of contents
Investor Testimonials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
Summary of Investment Opportunity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
1. Product and services. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
2. Investment Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
3. Details of the Investment Opportunity . . . . . . . . . . . . . . . . . . . . . . . . . . . . .17
4. Overview of the Business . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
5. Case Studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
6. Market Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .28

7. Directors and Management Team . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
8. Corporate Governance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .41
9. Revenue Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ... 42
10. Investment Risks .................... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ....47
11. Other Material Information. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51

12.Glossary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
www.pollenizer.com/invest 9
1 Products
and services
Click2Clinic Healthcare Inc
Bridges Healthcare Providers and Patient communities Globally
Service Providers
Doctors
Den8sts
Demand vs Supply Nurses
Physiotherapists
Nutri8onists
Medical Shops
Diagnos8c centers
Healthcare Buyers Hospitals
Home Health care Nursing Homes
Virtual Video consulta8ons
Appointment booking
Hospital admissions
Drug users
Diagnos8c service users
Second Medical opinion seekers
Medical Tourism seekers
ClinicopediaTM is a Mobile Digital
pla3orm and Social Network that
connects Demand side of Healthcare
Seekers and Supply chain of
Healthcare Providers
ClinicopediaTM is Social Network App for Health
Like FacebookTM for freindships, LinkedinTM for Business
Like TinderTM for DaAng ConnecAons and Instant messaging
PaAents can Discover, Connect, Chat with other PaAents with Same
Clinical Disorder
PaAents can Connect with other paAents , doctors , nurses of any of
the Thousands of Hospitals listed city wise Globally
1400 Clinical disorder Mobile Discussion forums
20000+ Pa8ent educa8on videos categorically posted in 1400
Clinical disorder groups
Clinicopedia- Provider TM is Supply Chain Mobile App
for Healthcare Providers to receive demand requests
from paAents and Bid the best oer price and
availability to deliver service
Click2Clinic Unique Digital Healthcare Strategy
Build Billions of PaAents on Social Network App ClinicopediaTM
Connect them to Consume Healthcare Services from Millions of Healthcare
Providers Supply chain on Clinicopedia ProviderTM
Clinicopedia- Provider TM Mobile App PlaHorm has 4

modules
HomeHeal TM
HealthCall TM
HealthBid TM
Clinicopedia TM
Connected Clinical Communities
a) Problem to solve
72% of internet users say they looked online for health information within the past year1. 60%of
adults got information or support from friends and family. 24% of adults got information or support
from others who have the same health condition. 31% of cell phone owners, and 52% of smart
phone owners, have used their phone to look up health or medical information.
b) Solution we offer
ClinicopediaTM is a social community and messenger app that enables people to become
members of patient support groups for 1500 common clinical conditions. We have seen similar
social platforms emerge for professionals (LinkedIn), social friendships (Facebook), love relations
(Tinder). ClinicopediaTM is mobile social networking platform for Health. The users can search
other members in the group into which they are enrolled and send friend request to connect .All
connected members can text chat, share images, Videos with each other. ClinicopediaTM has
managed Discussion board on mobile app where patients can post their health related queries
and both doctors and peer patients can post their replies and the Moderator edits the content.
ClinicopediaTM has video library of 5-6 hours of video on patient education on each of the 1200
Clinical condition. The Video content has evidence based guidelines on treatment, well
researched video on symptoms,signs,diagnosis, treatment options, prognosis, successful patient
experiences.The content of video library is constantly updated. ClinicopediaTM also provides Live
Health Talk shows by eminent clinicians and medical experts globally who discusses about the
specific clinical disorder management and patients attend interactive streaming video broadcast
on app along with text chat. ClinicopediaTM will be the core applauncher which millions of people
down load for connectivity and social activity and all other apps including HomeHealTM,
HealthCallTM, HealthCloudTM, HealthBidTM are provided as value added apps within the launcher.
c) Revenue Model
Click2Clinic charges annual subscription fee of 10 USD for subscription to Patient education
Video content .The Live Talk Shows by Medical experts are booked by patient for a price of 2
USD per ticket to show. Click2Clinic earns ad-revenue from OTC products advertisements by
Nutraceuticals and Pharmaceuticals.
1 Source : http://www.pewinternet.org/fact-sheets/health-fact-sheet/
250 Hospitals
250 Diagnostic Centers
3000 Pharmacy Stores
1,44,000 Doctors and Nurses
HealthBid
TM
Buy Health At Your Price
a) Problem to solve
There is a huge Supply Demand mismatch , Price and quality variation among Healthcare
Services is high including Doctor , Nurse , Physiotherapist Services and Pharmacy, Diagnostic
services, Hospital care services . Insurance coverage is significantly low and Private sector
participation in Healthcare Service delivery is high . Millions of patients want to choose the Lowest
Price Deal of the Day , Nearest to their Home with Best peer reviewed on quality of services .
HealthBidTM is a dynamic reverse bidding and auction app for Healthcare Services. Patients can
upload the prescription and request the quantities of drugs that he needs. All Medical Shops in
the neighborhood empaneled on HealthBidTM provider app can check the availability of
medicines; brands prescribed by the doctor and bid the best price they can offer. Similarly for
Diagnostic services, Home Healthcare by Nurses, Physiotherapists, Doctors, Care takers and
Nursing Aids, Hospital admissions are all dynamically bid for the best price of the day and
patient can choose among the bidders based price factor, geographic proximity, reviews by
other patients. Patients make in-app payment and receive the services.
c) Revenue Model
Click2Clinic charges a handling fee of 5% -10% of bid value on every successful bid that won the
auction. We also charge annual subscription fee of 100 USD from Medical shops, Diagnostic
centers, Nursing homes and Hospitals for providing and hosting them with the Provider App.
TM
HealthCall
Virtual Video Consultation App
a) Problem to solve
The doctor spends in the consultation room an average of 3.5 minutes with each patient, ask 3.2
questions(2) .15 64% of the patients had to wait for more than 3 hours for a Cardiac consultation
with 24% of patients waiting anywhere between 2 hours to three hours. Only 6% of patients could
have their consultation within one hour Many patients dream to be in safe cocoon of Health Radar
of their consultant and like to take follow up consultation by text chat or Video Chat 44% of the
12,500 patients for whom surgery was recommended were advised against it by their second
opinion consultants in a study reported by Times of India 3.In a study on 6791 patients Second
opinions often resulted in changes in diagnosis (14.8%), treatment (37.4%), or changes in both
(10.6%). Clinical impact was estimated as moderate/major in 20.9% of cases for diagnosis and
30.7% of cases for treatment.
HealthCallTM is a mobile app for patients to book appointment for Clinic Consultation, Video Chat
Consultation, Text Chat Consultation with their Medical consultant, It enables doctors assistant to
set appointment time, patients receive push notifications, upload clinical images, clinical videos,
lab reports, make in-app consultation fee payment. Doctors can create Healthcare Prepaid
Packages offering certain number of Video consultations and Text Consultations. Doctors can
provide e-prescriptions at the end of consultation. HealthCallTM has Hospital Version where a
Hospital can offer their resident clinicians virtual consultations to patients and can offer Health
care Prepaid Packages. Patients can Search and discover the best Medical experts globally,
upload their clinical images, lab reports, case history and seek appointment for 10 minute Video
consultation and make in-app payment of consultation fee.
c) Revenue Model
Click2Clinic charges a handling fee of 25 cents on every virtual consultation from patients. We
also charge annual subscription fee of 200 USD from Clinicians for providing and hosting them
the Provider app.
2 Source: The World Health Report 2008: Primary Health Care : Now More Than Ever By World Health Organization Page number 44
3 Source: http://timesofindia.indiatimes.com/india/44-advised-unnecessary-surgery-2nd-opinion-giversarticleshow/45746903.cms
Malaysia has 3 Million Geriatic
Patients
TM
HomeHeal
Cure At Your Cocoon
a) Problemtosolve
Malaysia has over 3 million of its citizens over the age of 65 Home healthcare has the potential to
replace up to 65% of unnecessary hospital visits , and costs up to < 20%incurred on hospital costs.
b) Solutionweoffer
HomeHealTM is a mobile app where patients can localize on GPS based interface, the nearest
doctor , nurse , physiotherapist available and raise request for home visit . Healthcare providers
with HomeHealTM Provider app, receive the requests and accept the request and delivers Home
care. Click2Clinic does due diligence of medical qualification and empanels Health care
providers willing to deliver Homecare service and activate their subscription on app. Patient
makes in-app payment of Consultation fee of Healthcare providers on app.
c) RevenueModel
Click2Clinic charges a connection charge of 50 cents on every Home Visit.
2 Investment
Overview
2.1 NOTICE
This section is an overview only and is not intended to provide full information
for investors intending to invest in the Company. This IM should be read and
considered in its entirety.
2.2 CLICK2CLINIC HEALTHCARE INC OVERVIEW
The Click2Cinic Healthcare Inc is comprised of:
(a) Parent Company this entity is incorporated as a corporation in Delaware

and holds all of the issued capital in Click2Clinic Healthcare Inc.
(b) Click2Clinic Healthcare India Pvt Ltd reaching 1.78 Billion population in
7South East Asian Countries namely India, Bangladesh, Pakistan, Nepal ,
Sri Lanka, Maldives , Bhutan .
(c) Click2Clinic Inc incorporates ten regional subsidiaries for convenience of

Trade, Commerce and operations in its global expansion plan
namelyClick2Clinic North America LLC , Delaware, Click2Clinic United
Kingdom LLP ,London , Click2Clinic Europe PCC LTD ,Gibraltar ,
Click2Clinic SEAN Pte Ltd ,Singapore , Click2Clinic Africa Ltd ,Nairobi,K
enya ,Click2Clinic China Co. Ltd ,Bejing,C hina , Click2Clinic Latin America
Buenos Aires ,Argentina.
Click2Clinic Healthcare Inc.
Stockton California
10 Subsidiaries , 238 Countries Join ventures

Digital Healthcare to 7454 Million population
2.3 BUSINESS OF CLICK2CLINIC GROUP
(a) Business Summary
Click2Clinic Healthcare Inc. is a Marketplace where we aggregate and create supply chain
of Doctors, Dentists, Nurses, Physiotherapists, Care takers, Medical Shops, Diagnostic
centers, Nursing Homes, Hospitals, Drug distributors, Pharmaceutical companies, Medical
Device Retailers and Distributors. Click2Clinic Healthcare Inc. creates demand side of
business by bringing billions of patients globally on our Mobile patient engagement
platform. We offer the Healthcare services offered by our supply chain showcased on the
Mobile patient engagement platform and enable the patients to consume the services on
demand.
1) Click2Clinic's goal is to become mobile platform for patients of same clinical
condition to get connected, invite friends, chat and form support. We create a
repertoire of video library of patient education video content on 1200 disorders from
42 sub specialties of healthcare
2) Click2Clinic provides, peer supported and medical expert moderated mobile
discussion forum for clinical problems of patients.
3) Click2Clinic empanels and aggregates after thorough due diligence and build a
supply chain network of Healthcare service providers including, doctors, dentists,
nurses, physiotherapists, caretakers, pharmacies, diagnostic centers, hospitals,
clinics, nursing homes. We provide a bidding app that enables the Healthcare
service providers to receive the request and bid their price to provide services to
patients in the neighborhood localized on GPS from the patient app.
4) Click2Clinic is the platform that bridges billions of patients downloading the social
networking app Clinicopedia with millions of Healthcare service providers empanelled
on the bidding app HealthBid.
(b) Click2Clinic Group Revenue Model

The Click2Clinic Healthcare Inc main sources of revenue come
from four broad categories, namely
1) Annual Subscription to app by Healthcare Providers to make them visible to

Patients globally to offer their services
2) Connection fee charged by Click2Clinic whenever a successful transaction
occur and in-app payment is done by Patients globally to receive Healthcare
services from the providers.
3) Subscription fee for consuming Video on demand services of Patient
education Video content by patients .
4) Connection fee charged by Click2Clinic whenever one Healthcare Provider
network e.g Pharmacies transacts with other network e.g Medical Drug
distributors
2.4 USE OF FUNDS RAISED
The purpose of the Investment Opportunity is to raise capital for the Click2Clinic Malaysia Sdn Bhd to:
(a) Market and increase Clinicopedia - Social Network for Health App patient downloads
across Malaysia .
(b) Create workforce to build supply chain network and B2B corporate tie-ups.
(c) Provide working capital to meet ongoing costs of the Company ; and
(d) Explore opportunities to create B2B Corporate tie-ups with Healthcare providers and
Hospitals.
2.5 KEY RISKS

Investment in the Company is speculative and will involve significant risks. Key risks include:
(a) SpeculativeInvestments:The key investments into Click2Clinic Malaysia Sdn Bhd is into
Digital Healthcare Startup. Startups are, by their nature, inherently speculative
investments;
(b) NomarketforShares:There is no established market for trading the Shares and investors
of the Company may find it difficult to dispose of their Share holding in the Company at a
particular time;
(c) Nodividendsmaybedeclared:Dividends may not be declared by the Company. Any
dividend payment will be subject to the Companys ability to meet any of its then cash
funding requirements for growth taking into account the capital and trading requirements
at that time. The Company is not in a position to predict when it will pay a dividend;
(d) Additionalcapitalrequirements:The Company may require additional capitalfrom time to
time.
Prospective investors should carefully review section 10 of this IM, which sets
out further information on these risks and other risks for the business and
investors in the Company.
2.6 DIRECTORS
The Company has appointed the following 3 directors to manage the Click2Clinic Healthcare India Pvt Ltd
business.
(a) Mohan Manthiry;
(b) Vivek Reddy Y;
(c) Suresh Meenakshisundaram ;
Each have signicant experience, which is detailed in section 7 of this IM.
3 Details of the
Investment
Opportunity
3.1 INVESTMENT OPPORTUNITY
The Directors are pleased to offer investors an opportunity to acquire Shares
in the Company in accordance with this IM.
The Company is seeking to rise up to $ 1 Million and is providing an

opportunity to investors to apply for a maximum of 66,66,667 fully
paid ordinary shares in the Company at an issue price of $0.15 per
Share.
3.2 MINIMUM SUBSCRIPTIONS FOR THE INVESTORS

The minimum subscription for Shares will be $ 18,000 (1,20,000 Shares).
3.3 ADDITIONAL SUBSCRIPTIONS FOR THE INVESTORS

If an investor wishes to subscribe for more than the minimum number of Shares,
such Subscriptions must be made in $4500 increments.
3.4 ACCEPTING AN APPLICATION

The Company is under no obligation to accept any application for Shares. The
Directors may, in their absolute discretion, reject or scale back any application
for Shares, without assigning any reasons for their decision.
3.5 APPLICATION MONIES
(a) Deposit of Subscription Monies
The Subscription Monies will be deposited in the Click2Clinic Malaysia Sdn Bhd
Offer Account.
(b) Refunds of Subscription Monies
If all or any part of an application is not successful, the Subscription Monies (or a
proportion of it, if applicable) will be refunded out of the Click2Clinic Malaysia
Sdn Bhd Offer Account. Interest will not be paid on any Subscription Monies,
which are refunded. Any refund due to an applicant will be refunded by either
(at the Companys election ;
(1) depositing it into the applicants designated bank account, as specified in

the Online Application Form or Paper Application Form; or
(2) paying it by cheque payable to the applicants name and posted to the
address specified on the Online Application Form or Paper Application
Form.
(c) Interest
The Company is entitled to retain any interest accrued on the Subscription

Monies, whether or not Shares (the subject of those Subscription Monies) are
allotted and issued.
3.6 U S E OF FUNDS RAISED
Purpose Use of Funds
Malaysia Market Development $666,667

Working Capital 15 months
Employee & contractor expenses $100000
Professional services $100000
Operating expenses $100000
Total Working Capital $300000
IM related costs $33333
Total $ 1000000
Timeframe: The $1,00,000 raised is expected to meet the marketing and working
capital requirements of the Click2Clinic Malaysia Sdn Bhd operations until March
2019.
Marketing costs: Capital will be invested into creating 10 Million Clinicopedia
App downloads by Health seekers and 168502 Healthcare provider supply
chain network across Malaysia .
Working Capital: As depicted by the table, funds raised as a result of this IM will also
form part of the Companys working capital and may be used for purposes that will
include costs that support the development of the intellectual property to increase
the success rate of businesses. It also includes costs associated with the attraction,
selection, business setup and ongoing management of the corporate tie-ups. It also
includes employee salaries, contractor fees, insurance, financial and legal advisory
fees, rent expenses, office equipment including computers, software licenses etc.,
expenses related to staff training, welfare and development and other operating
and administrative expenses that the Click2Clinic Malaysia Sdn Bhd incurs from time
to time, in the ordinary course of business.
Surplus Funds
If the Directors accept additional applications for Shares above the maximum
subscription amount, it is intended to apply the surplus funds to rapid expansion
of foot print of business across Malaysia . The Company may also increase
working capital expenditure with the aim of adding value to the business of the
Company . Investors should be aware that if circumstances change or better
opportunities arise, the Directors reserve the right to vary the proposed use of the
proceeds to maximize the benefit to the Company.
IM Related Costs
The IM related costs referred to in the table above, are the total estimated costs of
raising capital including fees and commissions, advisory and miscellaneous
expenses.
3.7 CAPITAL STRUCTURE
The share capital structure of the Click2clinic Malaysia Sdn Bhd currently and
upon completion of the Investment Opportunity, assuming the maximum total
subscription is achieved, will be as follows:
Details No. of Shares

Shares on issue at the date of this IM 16521739
Maximum number of new Shares to be issued 6666667
Total Shares 23188406
As at the date of this IM, the Company has the following Existing Options:
Details No. of Existing Options
Existing Options on issue 5797101
Total Existing Options 5797101
The total diluted capital structure (assuming all Existing Convertible Notes are
converted into Shares) on exercise of all Existing Options would be as follows:
Total Diluted Shares and Options 28985507
4 Overview of
the Business
4.1 HISTORY OF THE CLICK2CLINIC GROUP
Click2Clinic Healthcare Inc. is in the business of Healthcare Services delivery

enabled by Mobile Technology, founded as of January 2016. Click2Clinic
Healthcare Inc. is a Marketplace where we aggregate and create supply chain of
Doctors, Dentists, Nurses, Physiotherapists, Care takers, Medical Shops,
Diagnostic centers, Nursing Homes, Hospitals, Drug distributors, Pharmaceutical
companies, Medical Device Retailers and Distributors. Click2Clinic Healthcare Inc.
creates demand side of business by bringing billions of patients globally on our
Mobile patient engagement platform. We offer the Healthcare services offered by
our supply chain showcased on the Mobile patient engagement platform and
enable the patients to consume the services on demand.
Click2Clinic's goal is to become mobile platform for patients of same clinical

condition to get connected, invite friends, chat and form support. We create a
repertoire of video library of patient education video content on 1200 disorders
from 42 sub specialties of healthcare.
Click2Clinic provides, peer supported and medical expert moderated mobile

discussion forum for clinical problems of patients. Click2Clinic empanels and
aggregates after thorough due diligence and build a supply chain network of
Healthcare service providers including, doctors, dentists, nurses, physiotherapists,
caretakers, pharmacies, diagnostic centers, hospitals, clinics, nursing homes. We
provide a bidding app that enables the Healthcare service providers to receive
the request and bid their price to provide services to patients in the neighborhood
localized on GPS from the patient app.
Click2Clinic is the platform that bridges billions of patients downloading the social
networking app Clinicopedia with millions of Healthcare service providers
empanelled on the bidding app HealthBid.
Stage and status of the company
Click2Clinic Healthcare Inc. is incorporated as Corporation in State of Delaware, USA on January

13, 2016. The primary reason for such incorporation is long term vision to grow the company as
Multi National Corporation with global expansion and implementation of technology and business
practices worldwide. India with 1.3 Billion population is chosen as the first country
We created mobile technology platform that builds a supply-chain network of Healthcare Service
providers empanelled and on-boarded on mobile apps known as HomeHealTM, HealthCallTM,
HealthCloudTM , HealthBidTM.
Our 16 member Engineering team also built mobile app known as ClinicopediaTM that enables
Social networking between patients to form support groups, subscribe to Patient education Video
Library on demand, request for Home-visit of Doctor, Nurses, Physiotherapists, take appointment
for Video consultation, request our Healthcare Provider Network to bid for lowest price offer of
Healthcare Services.
4.2 CLICK2CLINIC IN INDIAN PENINSULA AND NEIGHBOURING COUNTRIES
Click2Clinc Inc. incorporated its wholly owned subsidiary Click2Clinic Healthcare India Pvt Ltd in
Hyderabad on Feb 24 , 2016 , to develop the business in India and its neighboring countries
namely Bangladesh, Pakistan, Nepal, Sri Lanka, Maldives, Bhutan.
The Directors consider that India is an ideal base for the Companys Indian Peninsula expansion
due to its friendly business climate, low taxes, robust capital markets and aggressive government
support for the Startup ecosystem .
The main goal for subsidiary Click2Clinic Healthcare India Pvt Ltd is to provide deal flow for the
Company and since its establishment, the Company has met with hundreds of potential
entrepreneurs and co-founders, Hospitals and bootstrapping Healthcare startups and is hopeful of
announcing its first investments in the neighboring countries shortly. Since its launch, Click2Clinic
Healthcare Inc has built strong relationships with entrepreneurs, investors, government officials
and journalists across South East Asia, thus greatly expanding the reach and power of the
Companys network.
4.3 BUSINESS OF THE CLICK2CLINIC HEALTHCARE INDIA PVT LTD
The Click2Clinic Healthcare India Pvt Ltd has Profits from the Revenue generated in India as the
main source of revenue and share of profits and valuation it makes in all the subsidiary companies
in India and the surrounding countries namely Bangladesh, Pakistan, Nepal, Sri Lanka, Maldives,
Bhutan.
5 Case Studies
5.1 MARKET CASE STUDIES

The increased level of activity in the Healthcare technology sector indicates that
there is rapid evolution occuring within the seed/early stage/Series A funding
ecosystem. This section looks at the success of Digital Health Startups in
recent years.
Healthcare Startup Funding Founded Headquartered Investors
Year
Vicare Undisclosedamount in 2016 2016 Vietnam Japan's CyberAgent Ventures andSingapore'sPix

Vine Capital.
mClinica Undisclosed amount in 2014 2005 Singapore, 500 Startups, Japans IMJ Investment Partners,
Philippines and Kickstart Ventures in the Philippines.
DocDoc 8.6 Million USD in Series A in 2015 2008 Singapore Hong Leong Financial Group, Sparklabs Global
Ventures
Attune technologies $10M in Series B funding in October 2015 2005 Singapore Qualcomm Ventures and Norwest Partners
ConneXionsAsia $8 million in Series A in Feb 2015 0.5 2013 Singapore NSI Ventures
RingMD Million USD in Feb 2013 2013 Singapore Singapores National Research Foundation
OurHealthMate 0.44 Million USD in Jan 2014 2015 Singapore Angel investors Bimal Shah,Benjamin Tsai, Ben Ball
JustDoc Undisclosed SeedFund in Jan 2016 2013 India TracxnLabs, Angel investors Infosys director TV
Mohandas Pai, InMobi co-founder Mohit Saxena,,
Raghunandan G (co-founder TaxiForSure),
Singapore Angel Network
iClinicq Undisclosed amount in June 2016 2013 India Angel investor Erode-based laparoscopic surgeon
Madhan Kumar Madathupalayam
Prescribez 145000 USD in May 2016 2016 India Angel investor Ankush Mehta
DocsApp $1.2 million Seed investment 2015 India Rebright Partner and early Facebook investors
Anand Rajaraman and Venky Harinarayan
SeeDoc 1 Million USD preSeries A July 2016 2015 India YourNest Angel Fund
DoctorInsta Initial Angel fund 50000 USD in Dec 2015 and $1 2015 India Angel investor Rishi Parti and BrahmaX Ventures
million in September 2016 and Seed A from RoundGlass Partners
Lybrate 2014 India Tiger Global Management, Nexus Venture

10.2 Million USD July 2015
Partners
Medifi 0.5 million USD in November 2016 2015 Philippines Angel investors
Alodokter 2.5 million USD in August 2016 2014 Indonesia Golden Gate Ventures
Dokter.id Undisclosed in March 2015 2013 Indonesia RingMD
Halodoc 13 million USD in September 2016 2016 Indonesia Clermont Group
MeetDoctor 380k USD Seed on May 6, 2013 2011 Indonesia Angel investors
1Health Undisclosed amount in 2016 2005 Indonesia Lippo Group
Konsula Undisclosed in Oct 2015 2015 Indonesia East Ventures
5.2 CASE STUDIES IN HEALTHCARE TECHNOLOGY STARTUPS IN SOUTH EAST ASIA
(a) Vicare
Has database of more than 19,000 clinics and 20,000 doctors around the country,
Records 200,000 visits a month and 3,000 comments and 6,000 inquiries
(b) mClinica
mClinica is a mobile health platform that connects drug companies directly to

pharmacies in emerging markets in Southeast Asia, which helps solve the problems
of fragmented supply chains and the high cost of medicine. Patients can avail of
discounts on medicines by providing their mobile phone numbers, and pharmacies
can send the transaction details to the platform in order to get reimbursed by the
drug companies. In turn, drug companies gain access to valuable sources of patient
data.
(c) DocDoc
DocDoc is a website that provides healthcare information and a reservation system

for booking medical appointments online. Its expansive network of healthcare
providers includes over 18,500 physicians in Asia.There are currently 500 paying
doctors on the service and another 20,000 in the companys global directory. The
company boasts it has connected 15,000 unique patients with doctors in the past
six months. In Singapore, where the company is based, DocDoc charges a S$299
monthly fee for its services.
(d) Attune technologies
Attune develops software that utilizes cloud technologies for providing solutions to
healthcare delivery associations. Its solutions integrate labs, hospitals, pharmacies,
blood banks, radiology, medical IoT devices, insurance companies, and accounting
for more streamlined processes, resulting in increased revenues and improved
operational efficiency.
(e) ConneXionsAsia
ConneXionsAsia provides a market for healthcare and insurance services through

its corporate benefits aggregation platformakin to what TripAdvisor is for travel,
but for insurance/healthcare/wellness . Singapore-based ConneXions Asia (CXA) is
targeting US$100 million in revenue by 2019, up from its current US$6 million, after
successfully raising US$8 million in Series A funding.
(f) RingMD
Ring.md is healthcare communications platform that links patients with quality

doctors throughout Asia for online patient-doctor consultations. The offering enables
live phone or video consultations with world-class doctors with one click or
tap.Founded by Justin Fulcher, its CEO and chairman, it secured seed funding of US
$500,000 in February 2013 and also conducted its own equity investment in
Indonesian health & wellness portal, PilihDokter, in March 2015
(g) OurHealthMate
This startup has developed a platform that allows online medical appointment
reservationsmaking it easier for patients to book checkups and other services
with their physicians
(h) JustDoc
mClinica is a mobile health platform that connects drug companies directly to

pharmacies in emerging markets in Southeast Asia, which helps solve the problems
of fragmented supply chains and the high cost of medicine. Patients can avail of
discounts on medicines by providing their mobile phone numbers, and pharmacies
can send the transaction details to the platform in order to get reimbursed by the
drug companies. In turn, drug companies gain access to valuable sources of patient
data.
(i) iClinicq
icliniq charges patients for every subsequent query after the first question while it
charges a flat fee of Rs 299 for its video and phone consultation for 15 minutes. The
firm takes 21% of the total transaction charges as its fee and gives the rest to the
doctor. Patients from over 60 countries including the US, the UK, Nigeria, Turkey,
Pakistan, Ethiopia and Albania are using the platform. Currently, icliniq has about
1,200 doctors on its platform, of which close to 900 are from India and the
remainder from countries including the US, the UK, UAE, Singapore and Germany.
(j) Prescribez
ThingsMeet Solutions as partnered with Geriwell, a geriatric wellness foundation to

offer health services to senior citizen through their digital health management
platform Prescribez. Geriwell is focused on providing quality services to senior
citizens and currently has over 10,000 members. The partnership will enable
Geriwell members manage their medical needs through the app. This would enable
them to book doctors' appointments, maintain medical records, get communications
from doctors, receive regular health tips, get follow up reminder for appointments,
search for specialty doctors/equipment/medical.
(k) SeeDoc
The app claims to have more than six lakh users and processes roughly 500 video
consultations daily.
(l) DoctorInsta
1,000 consultations a day and hopes to have 250 doctors to consult five million consumers by the
year end. It has tied up with at least 20 large companies including Tech Mahindra, PayU and Punj
Lloyd.
(m) Lybrate
Lybrate, has signed up 90,000 doctors into his platform which enables one-on-
one doctor consultations, through phone or chat.
(n) Medifi
MEDIFI is building integrations with popular personal health devices and emerging
medical sensors to harvest your vitals automatically and accurately.
(o) Alodokter
8 million unique monthly visitors. Receives 1,000 patient questions daily, which are
tackled manually.Over 100,000 patient questions have been answered to date.
(p) Dokter.id
Healthcare Information Portal that helps indonesian people more aware to their
health
(q) Halodoc
Connects users to a network of licensed doctors and 1,000 certified partner

pharmacies.There are currently 18,600 doctors active in HaloDoc, available for
consulting for about 10,000 users. Integrated within the app is ApotikAntar, a
platform that connect users to certified pharmacies with personal delivery for
medications.
(r) 1Health
1Health is a portal to educate people on health issues but we dont want to stop at
just giving information; we want to offer services through an app where people can
consult doctors with an appointment or through video conference
(s) Konsula
Serve as marketplace to connect patients and doctors. 500 doctors have already
signed up for its platform
6 Market
Overview
6.1 MARKET OPPORTUNITY
Market Opportunity of the Digital Healthcare Services industry in India
neighboring countries namely Bangladesh, Pakistan, Nepal, Sri Lanka,
Maldives, Bhutan. Health care demand in Southeast Asia (SEA) is increasing
rapidly, driven by population growth rates that are expected to outstrip those
of other geographies, and an epidemiological shift from infectious diseases to
a chronic disease pattern matching western markets. Many of the economies
in SEA are struggling with a relatively underdeveloped public health care
system. The region has a chronic shortage of medical personnel: the
average number of physicians in SEA is 0.6 per 1,000, lower than that in
developed economies such as the UK (2.8), Germany (3.7), and the U.S. (2.4).
Digital Health initiatives rely heavily on having the right information in the right
place at the right time for use by the right clinician. To really use technology
effectively in health, we need systems to interact with one another to provide
the data required to make informed decisions about the delivery of care.
Digital healthcare is not about the technologies; its about new ways of
solving healthcare problems, creating unique experiences for patients and
accelerating healthcare providers growth. Over the longer term, digital
healthcare will help system-wide operations and organizations to deliver more
powerful healthcare.
Characteristics of
healthcare in Healthcare demand in emerging markets is growing, driven by a number of factors
emerging markets such as a growing population as well as an ageing population. With the growing
middle class and rising incomes, people are spending more on healthcare. Non-
communicable diseases such as diabetes are no longer rich country diseases and
their prevalence is increasing in emerging markets. In these countries most of the
healthcare infrastructure is concentrated in urban areas, while more than 50% of
the population lives in rural areas.
Ageing population
Growing population
Emerging markets will account for 21% Many emerging markets in the Asia-Pacific region
80% of the worlds elderly by 20501
are yet to reach their peak population3
Some emerging markets should 7%
expect a significant increase in the
portion of their population aged 65+ Vietnam Projected population growth (2015-2050)
between 2015 20502 30%
10% 8% China
increase Population in 2050
2015 108% Japan
Thailand Population in 2050 7%
2050 93% decrease
Philippines 65%
Increased prevalence of non-communicable 46% India Population in 2050 increase
diseases(NCDs) increase 165%
Population in 2050
146% Malaysia 50%
68% of total deaths globally occur due to NCDs; emerging
Population in 2050 increase
markets account for 75% of these deaths7 40% Indonesia 150%
Almost 200 million of the worlds 370 million people increase Population in 2050
140%
diagnosed with diabetes live in Asia8
Prevalence of diabetes Indonesia

as % of population8
3.4 8.6 Growing middle class
2012 2030 Thailand
Malaysia 2.3 4.1 of the global
3.2 8.5
2012
2030 2/3 rds
middle class
will be in
2012 2030 Asia-Pacific
by20304
Philippines Vietnam
2.9 0.9 2.6

8.1
2012 2012 2030
2030
Urban-rural divide Percentage of population in rural areas (2015)5

Over 50% of the emerging market in
Asia-Pacific live in rural areas6 50% 50% 56% 44% 66% 34% 67% 33%
Urban
Rural Thailand Philippines Vietnam India
OECD average
4.7
3.3
Japan
12.3
2.5
S. Korea
8.8
2.3
China
3.3
1.8
India
Vietnam Philippines
0.8
2.9 1.1
0.8 Thailand 1.2
0.8
2.2
0.4
Malaysia
2.0
1.6
Singapore
Hospital beds Indonesia
2.0
2.3 1.0
0.4
Physicians
Infrastructure and Talent Gap

Australia
3.9
Low Moderate High 4.4
Gap Gap Gap
Source: Business Monitor International, 2015; OECD Data, 2014
By 2035 the global shortage of Over 1/3 of countries Weak tertiary and continuing
healthcare professionals will suffering from this shortage medical educational system limits
reach13 million from are emerging markets11 quality of knowledge distributed
in emerging markets
7million today10
Patients Providers Payers
EMR Easier to read and understand Easy storage and retrieval; improved efficiency
and productivity
EHR Better diagnosis and treatment Coordination and informed decision-making Faster reimbursements
Personal Health Personal wellness management Consistency of information Links to healthcare
Records plans and lower claims
Remote Diagnostics Reduces duplicated tests and referrals Easy access Lower cost
Remote Monitoring Patient-centric integrated care Reduce emergency and re-admissions Lower cost
Telecare Access to specialist care Improves productivity and reduces burden of Lower cost
healthcare resources
mHealth Greater patient engagement and Proactive and targeted care
applications savestime
Big Data/Analytics Accurate diagnosis, better treatment Improves diagnostics and accuracy of treatment Lower cost
* EMR Electronic Medical Records; EHR Electronic Health Records
Netherlands
Denmark
Singapore
High
US
Germany
Japan
S. Korea
EHR Adoption*
Canada
Emerging Thailand Australia UK
Medium
markets China
Malaysia
India
Philippines
Low
Indonesia Vietnam
<25% 25%-70% >70%
Internet Penetration (2015) Population size
Paper-based/Traditional
digital health model New digital health model
Paper-based Digitisation Digitisation Disruption
Physician-centric Patient-centric
(Engagement)
Independent Integrated
Security Trust
From digitisation to disruption
DEMOGRAPHIC FEATURES OF MALAYSIA
Country Malaysia
Population in Millions 31
Ageing population in Millions 1.55
Urban versus Rural Population (% urban) 70
Urban Geriatric population in Millions 1
FACTS ON HEALTHCARE PROVIDERS SUPPLY

CHAIN IN MALAYSIA
Country Malaysia
Number of Pharmacies 3000

Hospital Beds in Private Sector 25,650
Number of Doctors 36,000
Number of Nurses 1,08,000
INTERNET AND SMARTPHONE USAGE IN MALAYSIA
Country Malaysia
Internet users in Millions 21

Smart Phone users -Millions 20
Active Social Media users accessing 15
Social Media on a Mobile device
(Target Downloads of Clinicopedia)
7 Directors and
Management
Team
7.1 DIRECTORS
(a) Dr Sujeeth Reddy Punnam MD

Founder and Chairman of Click2Clinic Healthcare Inc is accomplished
Interventional Cardiologist, practicing in Sacramento, California, USA and Visionary
in Telemedicine and Mobile Technology Applications that disruptively deliver
medical care .
(b) Dr Murali Bharadwaz Yadavalli MD

Co-Founder and CEO of Click2Clinic Healthcare Inc is Indias most renowned
Medical Educationalist, Physician and successful entrepreneur in e-learning in
medical education. He along with team of 160 medical teachers have developed
4000 hours of Video Content for Medical Licensing exam Test Prep and Medical
School exams. 150000 medical students and doctors across India attended his
medical classes with 1.5 Million views and 12000 Subscribers on his YouTube
channel www.youtube.com/onlinembbs. He is tailor-made for this opportunity
because he has profound knowledge on how the market conditions prevail in
Indian Healthcare ecosystem and leverages strong academic connections he has
among thousands of medical doctors across country who vouched to be part of his
mission to deliver quality healthcare across India and revolutionize the
Telemedicine practices disruptively.
(c) Mohan Manthiry
CEO at InfoMed, Heserved as an Administrative and Diplomatic Officer for the
Government of Malaysia in various positions at Ministry of Home Affairs, Ministry of
Education and Ministry of Health. He was involved in a number of healthcare
consultancy for Ministry of Health Malaysia, namely in the design and
implementation of a specialized pilot project on telemedicine, Hospital Information
System and in the implementation of Malaysian Case-Mix System for public
hospitals. He has been since 2011 actively involved with the Malaysia Healthcare
Travel Council to promote Malaysian Healthcare to regional countries, in particular
Bangladesh. He also publishes a quarterly magazine InfoMed for healthcare
professionals in Malaysia. The magazine is geared towards supporting the
Malaysian healthcare's highest standards of practice by providing up to date news
and information that documents the changes the industry currently experiences and
the evolving future trends.
7.2 ADVISORY BOARD
(a) Dr P.S.Reddy, M.D., Professor of medicine, Division of Cardiology,University of Pittsburgh School of Medicine .
Dr. PS Reddy is an exceptional clinician and humanitarian whose commitment to

helping others has advanced cardiovascular care both in the U.S. and around the
world,Dr. Reddy established MediCiti Hospitals in Hyderabad, India. The main facility
provides tertiary care to residents and another suburban facility provides primary
and secondary care to its attached medical college, MediCiti Institute of Medical
Sciences.In 1988 and 1989, Dr. Reddy traveled to Egypt several times to share his
expertise with area surgeons. He trained local cardiologists to perform mitral
valvuloplasty a minimally invasive procedure that helps to open a blocked heart
valve. Since then, this procedure has benefited thousands of underserved patients in
Egypt.Dr. Reddy also served as director of the cardiac catheterization laboratory at
UPMC Presbyterian from 1972 to 1993.
Dr. Reddy is the recipient of numerous professional honors including the Award of
Excellence from the American Telugu Association (1996), Distinguished Physician
Award from the American Association of Physicians from India (1995-96), Tamil Nadu
Dr. M.G.R. Medical University Madras: Doctor of Science degree (1996), University of
Pittsburgh Chancellors Distinguished Public Service Award (2000), Outstanding
Community Service Award from the American College of Chest Physicians (2001),
and Clinical Educator of the Year Award from the University of Pittsburgh School of
Medicine (2008). He also served as president of the Laennec Society of the
American Heart Association (1984) and has been appointed to fellowship of the Royal
College of Physicians in Edinburgh, U.K., the American Heart Association Council on
Clinical Cardiology, and the American College of Cardiology.
(b) Mr. N. Damodar Reddy
Mr. N. Damodar Reddy, also known as Dan, serves as the Founder, Chairman and
Chief Executive Officer at SutiSoft Inc. Mr. Reddy serves as Advisor of Sensorin, Inc.
He designed one of the first commercially available Dynamic Random Access
Memory (DRAM) devices. He co-founded Alliance Semiconductor Corp. and served
as its Chief Executive Officer from February 1985 to December 1, 2005, Interim
Chief Financial Officer from July 11, 2005 to December 1, 2005 and President from
February 1985 to December 1, 2005. He also served as Chief Financial Officer of
Alliance Semiconductor Corp. from June 1998 to January 1999 and also again from
May 2001 to April 2002. Mr. Reddy served as President and Chief Executive Officer
of Modular Semiconductor Inc. from September 1983 to February 1985. He served
as Manager of Advanced CMOS Technology Development at Synertek Inc., a
subsidiary of Honeywell Inc. from 1980 to 1983. Prior to that time, Mr. Reddy held
various research and development and management positions at Four Phase
Systems, a subsidiary of Motorola Inc., Fairchild Semiconductor and RCA
Technology Center. He serves as the Chairman of Shimon Systems, Inc. and
HealthMicro Inc. He served as the Chairman of Athena Semiconductors, Inc. He
served as the Chairman of Alliance Semiconductor Corp. since February 1985. He
serves as a Director of HealthMicro Inc. He serves as a Director of Legacy Systems.
He served as Director Genesis Microchip Inc. and eMagin Corporation. Mr. Reddy
serves on the Board of Directors of many privately held companies, including
several companies in which Alliance Venture Managements investment funds hold
equity interests. Mr. Reddy served as a Director of Tower Semiconductor Ltd. since
January 2001. He served as a Director of Tharas Systems Inc. He served as a
Director of Alliance Semiconductor Corp. from February 1985 to June 20, 2006. Mr.
Reddy served as a Director of Sage Inc., since October 1996. In 1995, Mr. Reddy
was selected as Entrepreneur of the Year in Northern California, an award
sponsored by Inc. magazine, Ernest and Young and Merrill Lynch. Mr. Reddy holds
a B.S. degree in Electrical Engineering from Osmania University, M.S. degree in
Electrical Engineering from North Dakota State University and an M.B.A. from Santa
Clara University.
(c) Ravindra Madduri M.Tech, MBA
Non-executive Director, Click2Clinic Healthcare Inc is the Director, Barclays,
London. He is alumnus of London Business School and serves advisory Board of
many startups across Europe. He is eminent Corporate Banker in Europe and
manages trans continental teams managing a business of 100 Million USD .He
brings enormous expertise from his experiences about the market dynamics in
developed economies across Europe and developing economies across Africa.
He helps Click2Clinic to nail the Business Model and Revenue flows in India and
Scale the operations globally.
(d) Srinivas Sattiraju Non-executive Director, Click2Clinic Healthcare Inc. is

Founder CEO, Delex Cargo India Pvt Ltd, Indias largest Cargo Logistics
Company, which is valued at 150 Million USD. He is a passionate mentor and
authority in Logistics and Operations Management. He adds a clear focus in
Business strategy to scale the operations of Click2Clinic Healthcare Inc. Pan
India.
7.3 MANAGEMENT TEAM
(a) Roger Chung CPA - CFO CLICK2CLINIC HEALTHCARE INC.

is a great mentor for many Silicon Valley Startups and a diligent financial auditor brings his vast
experience of charting realistic unit economics and revenue projections to nurture start up to
evolve from idea to IPO .
(b) Y. Vivek Reddy B.Tech MBA - COO, CLICK2CLINIC HEALTHCARE INC.

is a serial entrepreneur and co-founder of Geostat technologies, which is the major technology
provider to National skill development Council, Government of India. He is pioneer and founder
team of Telangana state popular startup incubator Spark10.
(c) Anil Kumar Palle MCA - CTO, CLICK2CLINIC HEALTHCARE INC.

is a passionate programmer with wide experience in Big Data, Analytics, Artificial Intelligence and
Signal R technology. He mentored many programmers as a Team lead in development of
Microsoft .NET frameworks. He drives a team of 12 engineering team as program architect.
Corporate
8
Governance
(a Summary
The Board is responsible for the overall governance of the Company. This includes
setting the strategic direction of the Company within the context of its objectives. In
addition to their role of pursuing the objectives of the Company, the Directors monitor
the business affairs of the Company, including those of its Joint venture Companies, on
behalf of Shareholders and have adopted corporate governance policies which are
designed to encourage Directors to focus their attention on accountability, risk
management and ethical conduct.
(b) The Board of Directors
The constitution of the Company provides that the Click2Clinic Malaysia Sdn Bhd
must have at least three directors at all times. Each of Dr Sujeeth Reddy Punnam ,
Dr Murali Mohan Yadavalli have a right to appoint a director for so long as they hold no
less than 2.5% of the total issued capital of the Company.
If the Companys activities increase in size, nature and scope, the size of the Board
may be reviewed and the optimum number of Directors required to adequately
supervise the Companys activities will be determined within the limitations imposed
by the constitution and as circumstances demand. The membership of the Board, its
activities and its composition are subject to periodic review.
The criteria for determining the identification and appointment of suitable candidates
for the Board include quality of the individual, background of experience and
achievement, compatibility with other Board members, credibility within the
Companys scope of activities, intellectual ability to contribute to the Boards duties
and physical ability to undertake the Boards duties and responsibilities.
The Board has an Audit, Risk Committee and an Investment Committee. The Directors
consider that the Company is not currently of a size, nor are its affairs of such
complexity, to justify the formation of other committees at this time. The Board as a
whole is able to address the governance aspects of the full scope of the Companys
activities and to ensure that it adheres to appropriate ethical standards.
(c Continuous review of Corporate Governance
The Directors consider on an ongoing basis how management information is presented
to them and whether such information is sufficient to enable them to discharge their
duties as Directors of the Company. The corporate governance policies of the Company
require that such information must be sufficient to enable the Directors to determine
appropriate operating and financial strategies from time to time in light of changing
circumstances and economic conditions. The Directors recognize that involvement in the
Digital Healthcare sector is an inherently risky business and that operational strategies
adopted should, not withstanding this risk, be directed towards improving or
maintaining the net worth of the Company. As the Companys activities develop in size,
nature and scope, the size of the Board and the development of governance practices
will be given further consideration.
9 Revenue
Model
Click2Clinic Malaysia Sdn Bhd has 2 sources of monetization in the Business Model
a) Patients who have downloaded Clinicopedia App are engaged to make

connections freely with other patients in various Clinical support groups . They are
then offered services by supply chain of Healthcare providers. Every time , a
connection happens and transaction done on the in-app payment gateway ,
Click2Clinic collects Connection fee. There is a 40.4755 Million USD potential
revenue opportunity from the revenue generated from the transactions on
Clinicopedia App
b) Healthcare Providers subscribe to Clinicopedia Provider App that enables them to
receive business orders to deliver Service. To remain empanelled on the
Click2Clinic Business Mobile platform , the providers pay annual subscription fee.
Similarly , patients who downloaded Clinicopedia App have opportunity to
subscribe to video libraries on patient education over 1500 Clinical Conditions .
There is 19.05 Million USD potential revenue opportunity from the revenue
generated from the annual subscriptions on Clinicopedia App
40.4755 Million USD Annual Market Size on Transactions on Clinicopedia App
HealthBid Pharma Sales
Pharmacy Stores 3000
Prescription Sales per day in Million 0.06
Prescription Sales per Year in Million 21.9
Revenue per sale on HealthBid Pharma app in USD 0.5
Revenue per annum in Million USD 10.95
HealthBid Diagnostics Sales
Diagnostic centres 250
Investigations per day in Million 0.005
Investigations per year in Million 1.825
Revenue per Sale on Health Bid app in USD 2
HealthBid Hospital
Number of Hospital Beds in Private Sector 25650
Number of Hospital admissions that happen per annumin Millions 1.3338
Revenue per Hospital admission on Hospital Bid App in USD 10
HealthCall
Active Social Media users accessing Social Media on a Mobile device in Millions 15
Revenue per Virtual Video Consultation per user in USD 0.5
Revenue on Virtual Video consultations per annum in Million USD 7.5
HomeHeal
Geriatric patients in Millions in Urban Cities 1

Number of Home Health Visits per annum in Millions 5
Revenue per Home Visit facilitation in USD 1
Revenue on Home Healthcare per annum in Million USD 5
19.05 Million USD Annual Market Size on Annual Subscriptions on App
HealthBid Pharma
Pharmacy Stores 3000
Annual Subscription Fee for HealthBid Login in USD 100
Total Annual Subscription Fee Revenue in Million USD 0.3
Diagnostic centres 250
HealthBid Hospital
Hospitals and Nursing Homes in Private Sector 250
HealthCall
Number of Doctors in active Specialist practice 36000
Annual Subscription Fee for HealthCall Login in USD 100
Clinicopedia
Active Social Media users accessing Social Media on a Mobile device in Millions 15
Clinicopedia Users paying for Ptient Education Content in Millions(10%) 1.5
Annual Subscription for Patient education Video Library in USD 10
Total Annual Subscription Fee Revenue in Million USD 15
Revenue Projections
The total Market opportunity from the revenues from Transactions and Subscriptions on mobile
technology platform annually is 59.52 Million USD . Click2Clinic Malaysia Sdn Bhd
and its joint venture partners target to achieve market share of 1% in the Year 1 ,
2% in the Year 2 and 5% in Year 3 in order to achieve the break even and
profitability for the total investment of $ 1 Million done .
TARGETS TO ACHIEVE
Year 1 Year 2 Year 3

Transactions on Clinicopedia App Total Market
(1%) (2%) (5%)
HealthBid Pharma Sales
Prescription Sales per Year in Million 21.9 0.2190 0.438 1.095
Revenue per annum in Million USD 10.95 0.1095 0.219 0.5475
Investigations per year in Million 1.825 0.0183 0.0365 0.09125

Revenue per annum in Million USD 3.65 0.0365 0.073 0.1825
HealthBid Hospital
Number of Hospital admissions that happen per 1.3 0.0133 0.0267 0.06669
annumin Millions
Revenue per annum in Million USD 13 0.1334 0.267 0.6669
HealthCall
Clinicopedia Downloads in Million 15 0.15 0.3 0.75

Revenue on Virtual Video consultations per 7.5 0.0750 0.15 0.375
annum in Million USD
HomeHeal
Number of Home Health Visits per annum in 5 0.0504 0.10075 0.251875

Millions
Revenue on Home Healthcare per annum in 5 0.0504 0.10075 0.251875

Million USD
Year 1 Year 2 Year 3
Annual Subscriptions on Clinicopedia App Total Market
(1%) (2%) (5%)
HealthBid Pharma
Pharmacy Stores that subscribe to HealthBid 3000 30 90 225

Total Annual Subscription Fee Revenue in Million USD 0.3 0.0030 0.009 0.0225
Diagnostic centres that subscribe to HealthBid 250 2.5 6 15
HealthBid Hospital
Hospitals and Nursing Homes in Private Sector 250 2.5 4.32 10.8
HealthCall
Number of Doctors in active Specialist practice (10%) 36000 360 200 500
Clinicopedia
Clinicopedia Users paying for Ptient Education Content 1.5

0.01 0.02 0.05
in Millions(10%)
Malaysia Year 1 Year 2 Year 3
Revenue in Million USD 0.595 1.191 2.976
Expenditure Million USD 0.476 0.714 1.191
Net Profit (Before Tax) in Million USD 0.119 0.476 1.786
10 Investment
Risks
Investors should consider the risk factors associated with
an investment in the Company including but not limited to
thefollowing:
10.1 BUSINESS SPECIFIC RISK
The Click2Clinic Malaysia Sdn Bhd is involved in the Startup industry. As startup
companies are in their early stage of growth and development, they may not
have fully developed customer bases and management and operation
processes in place. In addition to these uncertainties, startups have unknown
capital requirements. This could involve high risk and result in some of the
startup's not being successful. Additionally the Company will be exposed to
risks specific to the business that each startup operate in the economic, political
ecosystem specific to each of these countries.
10.2 ILLIQUIDITY OF SHARES IN THE COMPANY

Since the Shares are not listed on any stock exchange, Investors may find it
difficult to dispose their shareholding in the Company.It is not intended that the
Shares will be listed on a stock exchange.
10.3 ILLIQUIDITY OF SHARES IN JOINT VENTURE COMPANIES

Typically there is a very limited market for shares in Startups and early-stage
development companies. Accordingly, the investments held by the Click2Clinic
Malaysia Sdn Bhd is likely to be highly illiquid and the Click2Clinic Healthcare
India Pvt Ltd Group may be unable to realize an investment in an Joint venture
at any particular point in time.
In certain circumstances it may be difficult to exit or sell a startup, especially if

that startup has not performed to the best of its ability in creating growth and
profit.
10.4 MEDIUM TO LONG-TERM INVESTMENT
The nature of investing in Startups demands that there be a significant length of
time between initial investment and realization of gains. Early stage investments
take time to reach maturity and liquidity where exits are possible. Investment in
the Company is to be considered a medium to long-term investment.
10.5 RISK ON RETURN ON INVESTMENT

For investors, the return on investment will depend on the success of the
Click2Clinic Malaysia Sdn Bhd operating as subsidiary of Click2Clinic Healthcare India
Pvt Ltd which intern is the subsidiary of Click2Clinic Healthcare Inc, the Parent
Company. The Click2Clinic Healthcare India Pvt Ltd and the parent company
Click2Clinic Healthcare Inc provides no assurance that the Click2Clinic Malaysia Sdn
Bhd will generate income or produce returns. Neither the affiliates of the Company
nor the Directors guarantee any specific rate of return on the investments made by
investors.
10.6 ADDITIONAL REQUIREMENTS OF THE COMPANY FOR CAPITAL

The Click2Clinic Malaysia Sdn Bhd capital requirements depend on numerous factors.
The Company may require further funding in addition to amounts raised under
the IM. Any additional equity financing may dilute shareholdings. Debt
financing, if available, may involve restrictions on financing and operating
activities. If the Company is unable to obtain additional financing as needed, it
may be required to reduce the scope of its operations and may adversely affect
the capacity of the Click2Clinic Malaysia Sdn Bhd to achieve its goals.
10.7 FUTURE CAPITAL RAISINGS BY CLICK2CLINIC MALAYSIA PVT LTD

Startup's, if they are successful, will require funding in addition to the capital
raised initially. If the initial investors of Click2Clinic Malaysia Sdn Bhd
do not contribute further capital, any future capital raising's will dilute
the shares.
10.8 ABSENCE OF DIVIDENDS

The Directors make no forecasts about any profits, dividends or distributions that
the Company may make. It is not anticipated that the Company will be able to pay
dividends, in the foreseeable future. If the Company does derive profits it is
possible that these will be reinvested to further the objectives of the Company.
10.9 LIMITED OPERATING HISTORY
The Company has a limited operating history. However, the holding company
Click2Clinic Healthcare Inc has a successful operating history in building mobile
technology.
10.10 LACK OF DIVERSIFICATION

At any time, the Click2Clinic Malaysia Sdn Bhd will have interests in Digital Healthcare
business. The Click2Clinic Malaysia Sdn Bhd will therefore be more susceptible
to fluctuations in value resulting from adverse business or economic conditions
affecting those regions.
10.11 ECONOMIC CLIMATE RISK

The investor must be aware that the success of a Healthcare startup is dependent to
some extent on the global economic environment and therefore growth may be
impacted from time to time on account of market conditions.
10.12 LOANS
The Directors have the discretion to decide whether the investment in the
Click2Clinic Malaysia Sdn Bhd will be by way of equity or loan. These decisions will
be decided on a case by case basis, dependent on the financial health , potential
risk factors attached to the investment and other broad macro-economic factors.
The loans extended to the Click2Clinic Malaysia Sdn Bhd may be unsecured and
investors should be aware that such lending activities may be risky and result in a
loss of capital in the event of a default. As far as practically possible, the Board will
Endeavor to reduce this risk by ensuring that the loan amount is a small fraction of
the total investment.
10.13 LEGISLATIVE CHANGE

Changes in government regulations and policies may adversely affect the financial
performance or the current and proposed operations generally of the Click2Clinic
Malaysia Sdn Bhd.
10.14 UNFORESEEN EXPENSES

While the Company is not aware of any expenses that may need to be incurred
that have not been taken into account, if such expenses were subsequently
incurred, this would have a negative effect on the financial position of the
Click2Clinic Malaysia Sdn Bhd.
10.15 KEY EMPLOYEE RISKS
The Click2Clinic Malaysia Sdn Bhd is heavily reliant on its ability to attract
new key personnel and retain existing key personnel. The Company heavily
rely on existing key personnel to maintain business and client relationships. If
the Company is unable to retain and motivate these key employees, it may
have a detrimental impact on the Click2Clinic Malaysia Sdn Bhd.
10.16 EXCHANGE RATE

The revenues, earnings, assets and liabilities of the Click2Clinic Malaysia Sdn Bhd
may be exposed adversely to exchange rate fluctuations.
10.17 LEGAL ACTION AGAINST THE COMPANY

There is a general risk that legal action may be taken against the Company. The
Company has no knowledge of any circumstances that may give rise to such
action or any threat of such action.
10.18 EFFECT OF COMPETITION

The advent of increased competition may result in lower than expected market share
and impact negatively on the business of the Click2Clinic Malaysia Sdn Bhd.
11 Other Material
Information
11.1 RIGHTS ATTACHING TO SHARES
A summary of the rights attaching to the Shares issued pursuant to an investment in

the Company, are set out below. This summary does not purport to be an exhaustive
or definitive statement of the rights and liabilities of the Companys Shareholders:
(a) Voting
At a general meeting of the Company, on a show of hands, every member present in
person or by proxy, attorney or representative has one vote and upon a poll, every
member present in person or by proxy, attorney or representative has one vote for
every Share held by them.
(b) Dividends
The Shares will rank equally with all other issued Shares and will participate in
dividends out of profits earned by the Company from time to time. Subject to the
rights of holders of shares with any preferential rights, the profits of the Company are
divisible amongst the holders of Shares in proportion to the Shares held by them,
irrespective of the amount paid up or credited as paid on them. The Directors may
from time to time pay to Shareholders such interim dividends as in their judgment
the position of the Company justifies.
(c) Winding up
Once an applicant has paid the Subscription Monies, they will have no further liability
to make payments to the Company if the Company is wound up under the US
Bankruptcy Code . Subject to the rights of holders of shares with any preferential
rights, the capital of the Company is divisible amongst the holders of Shares in
proportion to the Shares held by them.
(d) Transfer of Shares
Generally, the Shares will be freely transferable, subject to satisfying the usual
requirements for the transfer of Shares under the Companys constitution. The
Directors may refuse to register any transfer of Shares.It needs to be noted that the
Shares will be a relatively illiquid asset for investors as the Shares are not listed on
any exchange.
11.2 EXISTING OPTIONS
At the date of this IM, there are 5797101 Existing Options on issue in the
Company that are reserved to be issued to employees, Directors or their nominees.
11.3 MEDIUM TO LONG-TERM INVESTMENT

As at the date of this IM, there are no Convertible notes issued by
Click2Clinic Malaysia Sdn Bhd.
11.4 DIVIDEND POLICY

Subject to compliance with the United States corporate law and any other
applicable laws, the Board has absolute discretion to declare and pay dividends. It
will only do so if it considers that it is prudent and tax effective to do so.
The Directors may determine the quantum of dividends, if any, from year to year
having regard to matters such as current and expected financial performance in
the succeeding years, retained profit and available cash.
11.5 FUTURE FUNDING

(a) Borrowings
As determined by the Board, the by Click2Clinic Malaysia Sdn Bhd may in certain
circumstances obtain debt financing, as required
(b) Future Capital Raising's
The requirements for future capital depend on market opportunity. There may be
a requirement for funding in addition to the capital raised under this Investment
Opportunity. In such an event, the investors need to be aware that any future
capital raising's may dilute shareholding.
11.6 COPYRIGHT MATERIAL

This IM, including the diagrams and graphs contained in it, are the copyright of the
Click2Clinic Healthcare Inc.
11.7 CONSENTS
Each of the Directors have given, and at the date of this IM have not withdrawn their
consent to the issue of this IM and have authorised Dr Sujeeth Reddy Punnam, to
sign it.
12
Glossary
$ means United states of America dollars. All amounts in this IM are in United states
of America dollars unless otherwise stated.
Board means the board of directors of the Company.
Closing Date means 31 March 2017, or such later period determined by the Board in
its absolute discretion.
Company means Click2Clinic Malaysia Sdn Bhd
Directors mean the directors of the Company.
Existing Options means all existing options to subscribe for Shares currently on
issue as at the date of this IM.
Existing Convertible Notes means all existing convertible notes on issue as at the
date of this IM.
IM means this Investment Memorandum.
Investment Opportunity means the opportunity for investors to apply for a maximum
of 19,99,998 fully paid Shares at an issue price of $0.15 per Share.
IPO means an initial public offering of an IPO entity to the official list of the AMEX
Limited or any other recognized stock exchange.
Shares mean ordinary shares of the Company.
Shareholder means a shareholder of the Company.
Share Registry means Link Market Services Limited.
Startup means a newly created company mostly associated with technological
ventures, designed for high-growth and designed to search for a repeatable and
scalable business model.
Dated this 1st day of January 2017

Click2Clinic Malaysia - IM

Încărcat de

Informații document

Titlu original

Drepturi de autor

Formate disponibile

Partajați acest document

Partajați sau inserați document

Opțiuni de partajare

Vi se pare util acest document?

Este necorespunzător acest conținut?

Drepturi de autor:

Formate disponibile

Click2Clinic Malaysia - IM

Încărcat de

Drepturi de autor:

Formate disponibile

Click2Clinic Malaysia Sdn Bhd

PRIVATE AND CONFIDENTIAL

Telemedicine, Virtual Consults is the future

I founded a 250 Million dollar values

The main reason I invested in Click2Clinic is

Lot of times, startups build technology apps

Issuer Click2Clinic Malaysia Sdn Bhd

Price per Share $0.15

Minimum subscription per Shareholder ($) $18,000

Minimum parcel of Shares per Shareholder (Shares) 1,20,000 Shares

Minimum additional investments ($) $4500

Minimum additional investments (Shares) 30,000 Shares

Maximum total subscription ($) $1,000,000

Maximum total subscription (Shares) 66,66,667 Shares

Date of IM 1 Jan 2017

Closing Date 31 Mar 2017

Collection, maintenance and disclosure of certain personal information is governed by legislation

THIS DOCUMENT IS IMPORTANT AND SHOULD BE READ IN ITS

Summary of Investment Opportunity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4

1. Product and services. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8

3. Details of the Investment Opportunity . . . . . . . . . . . . . . . . . . . . . . . . . . . . .17

4. Overview of the Business . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21

6. Market Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .28

8. Corporate Governance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .41

9. Revenue Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ... 42

10. Investment Risks .................... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ....47

11. Other Material Information. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51

Clinicopedia- Provider TM Mobile App PlaHorm has 4

Connected Clinical Communities

Buy Health At Your Price

2.2 CLICK2CLINIC HEALTHCARE INC OVERVIEW

The Click2Cinic Healthcare Inc is comprised of:

(a) Parent Company this entity is incorporated as a corporation in Delaware

(c) Click2Clinic Inc incorporates ten regional subsidiaries for convenience of

10 Subsidiaries , 238 Countries Join ventures

(a) Business Summary

(b) Click2Clinic Group Revenue Model

1) Annual Subscription to app by Healthcare Providers to make them visible to

2.5 KEY RISKS

Each have signicant experience, which is detailed in section 7 of this IM.

The Company is seeking to rise up to $ 1 Million and is providing an

3.2 MINIMUM SUBSCRIPTIONS FOR THE INVESTORS

3.3 ADDITIONAL SUBSCRIPTIONS FOR THE INVESTORS

3.4 ACCEPTING AN APPLICATION

(1) depositing it into the applicants designated bank account, as specified in

The Company is entitled to retain any interest accrued on the Subscription

3.6 U S E OF FUNDS RAISED

Purpose Use of Funds

Malaysia Market Development $666,667

Details No. of Shares

Maximum number of new Shares to be issued 6666667

Total Shares 23188406

Details No. of Existing Options

Existing Options on issue 5797101

Total Existing Options 5797101

Total Diluted Shares and Options 28985507

Click2Clinic Healthcare Inc. is in the business of Healthcare Services delivery

Click2Clinic's goal is to become mobile platform for patients of same clinical

Click2Clinic provides, peer supported and medical expert moderated mobile

Click2Clinic Healthcare Inc. is incorporated as Corporation in State of Delaware, USA on January

4.2 CLICK2CLINIC IN INDIAN PENINSULA AND NEIGHBOURING COUNTRIES

4.3 BUSINESS OF THE CLICK2CLINIC HEALTHCARE INDIA PVT LTD

5.1 MARKET CASE STUDIES